Cargando…
Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence
Immunoglobulins (IGs) are widely used for the treatment of immunodeficiency syndromes and several autoimmune diseases. In neonates, IGs have been used for the treatment of alloimmune thrombocytopenia, in neonatal infections and in the rare cases of neonatal Kawasaki disease. This review aims to exam...
Autores principales: | Mahmood, Iftekhar, Tegenge, Million A., Golding, Basil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345246/ https://www.ncbi.nlm.nih.gov/pubmed/32575458 http://dx.doi.org/10.3390/antib9020024 |
Ejemplares similares
-
Dosing Considerations for Antibodies Against COVID-19
por: Tegenge, Million A., et al.
Publicado: (2020) -
Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
por: Kuemmel, Colleen, et al.
Publicado: (2019) -
Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
por: White, Nicholas J.
Publicado: (2013) -
Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
por: Belov, Artur, et al.
Publicado: (2021) -
Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs)
por: Mahmood, Iftekhar
Publicado: (2021)